212 related articles for article (PubMed ID: 17660609)
1. Study of therapeutic potential of the experimental pseudomonas bacteriophage preparation.
Dzuliashvili M; Gabitashvili K; Golidjashvili A; Hoyle N; Gachechiladze K
Georgian Med News; 2007 Jun; (147):81-8. PubMed ID: 17660609
[TBL] [Abstract][Full Text] [Related]
2. A controlled clinical trial of a therapeutic bacteriophage preparation in chronic otitis due to antibiotic-resistant Pseudomonas aeruginosa; a preliminary report of efficacy.
Wright A; Hawkins CH; Anggård EE; Harper DR
Clin Otolaryngol; 2009 Aug; 34(4):349-57. PubMed ID: 19673983
[TBL] [Abstract][Full Text] [Related]
3. Use of newly isolated phages for control of Pseudomonas aeruginosa PAO1 and ATCC 10145 biofilms.
Pires D; Sillankorva S; Faustino A; Azeredo J
Res Microbiol; 2011 Oct; 162(8):798-806. PubMed ID: 21782936
[TBL] [Abstract][Full Text] [Related]
4. Bacteriophages can treat and prevent Pseudomonas aeruginosa lung infections.
Debarbieux L; Leduc D; Maura D; Morello E; Criscuolo A; Grossi O; Balloy V; Touqui L
J Infect Dis; 2010 Apr; 201(7):1096-104. PubMed ID: 20196657
[TBL] [Abstract][Full Text] [Related]
5. [Bacteriophage phi297--the new species of temperate phages Pseudomonas aeruginosa with a mosaic genome: potential use in phagotherapy].
Burkal'tseva MV; Krylov SV; Kropinskiĭ AM; Pletneva EA; Shaburova OV; Krylov VN
Genetika; 2011 Jul; 47(7):900-4. PubMed ID: 21938953
[TBL] [Abstract][Full Text] [Related]
6. [Spontaneous phage production in Pseudomonas pseudomallei and in a range of hosts of melioidosis phages among representatives in the genus Pseudomonas].
Grishkina TA; Merinova LK
Mikrobiol Z; 1993; 55(4):43-7. PubMed ID: 7693232
[TBL] [Abstract][Full Text] [Related]
7. Bacteriophages of Pseudomonas aeruginosa: long-term prospects for use in phage therapy.
Krylov VN
Adv Virus Res; 2014; 88():227-78. PubMed ID: 24373314
[TBL] [Abstract][Full Text] [Related]
8. Transduction of antibiotic resistance in Pseudomomas aeruginosa: relationship between lytic and transducing activity of phage isolate AP-423.
Blahová J; Králiková K; Krcméry V; Jezek P
Acta Virol; 1999 Dec; 43(6):395-8. PubMed ID: 10825931
[TBL] [Abstract][Full Text] [Related]
9. Augmentation of the antimicrobial efficacy of antibiotics by filamentous phage.
Hagens S; Habel A; Bläsi U
Microb Drug Resist; 2006; 12(3):164-8. PubMed ID: 17002542
[TBL] [Abstract][Full Text] [Related]
10. Bacteriophage control of Pseudomonas plecoglossicida infection in ayu Plecoglossus altivelis.
Park SC; Nakai T
Dis Aquat Organ; 2003 Jan; 53(1):33-9. PubMed ID: 12608566
[TBL] [Abstract][Full Text] [Related]
11. Therapeutic effect of the YH6 phage in a murine hemorrhagic pneumonia model.
Yang M; Du C; Gong P; Xia F; Sun C; Feng X; Lei L; Song J; Zhang L; Wang B; Xiao F; Yan X; Cui Z; Li X; Gu J; Han W
Res Microbiol; 2015 Oct; 166(8):633-43. PubMed ID: 26254772
[TBL] [Abstract][Full Text] [Related]
12. Use of bacteriophage in the treatment of experimental animal bacteremia from imipenem-resistant Pseudomonas aeruginosa.
Wang J; Hu B; Xu M; Yan Q; Liu S; Zhu X; Sun Z; Reed E; Ding L; Gong J; Li QQ; Hu J
Int J Mol Med; 2006 Feb; 17(2):309-17. PubMed ID: 16391831
[TBL] [Abstract][Full Text] [Related]
13. Two Novel Bacteriophages Improve Survival in
Jeon J; Yong D
Appl Environ Microbiol; 2019 May; 85(9):. PubMed ID: 30824445
[TBL] [Abstract][Full Text] [Related]
14. Phage therapy of Pseudomonas aeruginosa infection in a mouse burn wound model.
McVay CS; Velásquez M; Fralick JA
Antimicrob Agents Chemother; 2007 Jun; 51(6):1934-8. PubMed ID: 17387151
[TBL] [Abstract][Full Text] [Related]
15. The adsorption of Pseudomonas aeruginosa bacteriophage phiKMV is dependent on expression regulation of type IV pili genes.
Chibeu A; Ceyssens PJ; Hertveldt K; Volckaert G; Cornelis P; Matthijs S; Lavigne R
FEMS Microbiol Lett; 2009 Jun; 296(2):210-8. PubMed ID: 19459952
[TBL] [Abstract][Full Text] [Related]
16. Analyses of Short-Term Antagonistic Evolution of Pseudomonas aeruginosa Strain PAO1 and Phage KPP22 (Myoviridae Family, PB1-Like Virus Genus).
Uchiyama J; Suzuki M; Nishifuji K; Kato SI; Miyata R; Nasukawa T; Yamaguchi K; Takemura-Uchiyama I; Ujihara T; Shimakura H; Murakami H; Okamoto N; Sakaguchi Y; Shibayama K; Sakaguchi M; Matsuzaki S
Appl Environ Microbiol; 2016 Aug; 82(15):4482-4491. PubMed ID: 27208109
[TBL] [Abstract][Full Text] [Related]
17. Utility of lytic bacteriophage in the treatment of multidrug-resistant Pseudomonas aeruginosa septicemia in mice.
Vinodkumar CS; Kalsurmath S; Neelagund YF
Indian J Pathol Microbiol; 2008; 51(3):360-6. PubMed ID: 18723958
[TBL] [Abstract][Full Text] [Related]
18. Survey of Pseudomonas aeruginosa and its phages: de novo peptide sequencing as a novel tool to assess the diversity of worldwide collected viruses.
Ceyssens PJ; Noben JP; Ackermann HW; Verhaegen J; De Vos D; Pirnay JP; Merabishvili M; Vaneechoutte M; Chibeu A; Volckaert G; Lavigne R
Environ Microbiol; 2009 May; 11(5):1303-13. PubMed ID: 19207572
[TBL] [Abstract][Full Text] [Related]
19. Characterization of lytic Pseudomonas aeruginosa bacteriophages via biological properties and genomic sequences.
Karumidze N; Thomas JA; Kvatadze N; Goderdzishvili M; Hakala KW; Weintraub ST; Alavidze Z; Hardies SC
Appl Microbiol Biotechnol; 2012 Jun; 94(6):1609-17. PubMed ID: 22562168
[TBL] [Abstract][Full Text] [Related]
20. [Autoplaque formation in a Pseudomonas fluorescens strain: phage-like particles and transactivation of the defective phage].
Shaburova OV; Kurochkina LP; Krylov VN
Genetika; 2001 Jul; 37(7):893-9. PubMed ID: 11558228
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
